nodes	percent_of_prediction	percent_of_DWPC	metapath
Boceprevir—ABCB1—Levothyroxine—hypothyroidism	0.135	0.28	CbGbCtD
Boceprevir—ABCB1—Liothyronine—hypothyroidism	0.135	0.28	CbGbCtD
Boceprevir—ABCB1—Liotrix—hypothyroidism	0.132	0.273	CbGbCtD
Boceprevir—CYP3A4—Levothyroxine—hypothyroidism	0.0808	0.168	CbGbCtD
Boceprevir—Hyperthyroidism—Dextrothyroxine—hypothyroidism	0.0109	0.0426	CcSEcCtD
Boceprevir—Hyperthyroidism—Levothyroxine—hypothyroidism	0.0109	0.0426	CcSEcCtD
Boceprevir—CMA1—heart—hypothyroidism	0.00828	0.0342	CbGeAlD
Boceprevir—Hyperthyroidism—Liotrix—hypothyroidism	0.00802	0.0314	CcSEcCtD
Boceprevir—CMA1—cardiovascular system—hypothyroidism	0.00781	0.0322	CbGeAlD
Boceprevir—CTSV—gonad—hypothyroidism	0.00742	0.0306	CbGeAlD
Boceprevir—CTSL—adrenal cortex—hypothyroidism	0.00732	0.0302	CbGeAlD
Boceprevir—CTSV—pituitary gland—hypothyroidism	0.00724	0.0299	CbGeAlD
Boceprevir—CTSL—heart—hypothyroidism	0.00708	0.0292	CbGeAlD
Boceprevir—CTSL—cardiovascular system—hypothyroidism	0.00668	0.0276	CbGeAlD
Boceprevir—CTSV—thyroid gland—hypothyroidism	0.00624	0.0258	CbGeAlD
Boceprevir—CMA1—adrenal gland—hypothyroidism	0.00618	0.0255	CbGeAlD
Boceprevir—CMA1—blood—hypothyroidism	0.00618	0.0255	CbGeAlD
Boceprevir—CTSL—gonad—hypothyroidism	0.00606	0.025	CbGeAlD
Boceprevir—CTSV—female gonad—hypothyroidism	0.00603	0.0249	CbGeAlD
Boceprevir—CTSL—pituitary gland—hypothyroidism	0.00591	0.0244	CbGeAlD
Boceprevir—Venous thrombosis—Liotrix—hypothyroidism	0.00587	0.023	CcSEcCtD
Boceprevir—CTSK—adrenal cortex—hypothyroidism	0.00552	0.0228	CbGeAlD
Boceprevir—CTSV—testis—hypothyroidism	0.00535	0.0221	CbGeAlD
Boceprevir—CTSK—heart—hypothyroidism	0.00533	0.022	CbGeAlD
Boceprevir—CTSL—adrenal gland—hypothyroidism	0.00528	0.0218	CbGeAlD
Boceprevir—CTSL—blood—hypothyroidism	0.00528	0.0218	CbGeAlD
Boceprevir—CTSL—thyroid gland—hypothyroidism	0.0051	0.021	CbGeAlD
Boceprevir—CTSK—cardiovascular system—hypothyroidism	0.00503	0.0208	CbGeAlD
Boceprevir—CTSL—female gonad—hypothyroidism	0.00493	0.0203	CbGeAlD
Boceprevir—CTSS—adrenal cortex—hypothyroidism	0.00483	0.0199	CbGeAlD
Boceprevir—CMA1—liver—hypothyroidism	0.00483	0.0199	CbGeAlD
Boceprevir—CTSS—heart—hypothyroidism	0.00467	0.0193	CbGeAlD
Boceprevir—CTSK—gonad—hypothyroidism	0.00457	0.0189	CbGeAlD
Boceprevir—CYP3A4—urine—hypothyroidism	0.00455	0.0188	CbGeAlD
Boceprevir—CTSK—pituitary gland—hypothyroidism	0.00446	0.0184	CbGeAlD
Boceprevir—CTSS—cardiovascular system—hypothyroidism	0.00441	0.0182	CbGeAlD
Boceprevir—CTSL—testis—hypothyroidism	0.00437	0.018	CbGeAlD
Boceprevir—Wheezing—Dextrothyroxine—hypothyroidism	0.00418	0.0164	CcSEcCtD
Boceprevir—Wheezing—Levothyroxine—hypothyroidism	0.00418	0.0164	CcSEcCtD
Boceprevir—CTSV—Endochondral Ossification—THRA—hypothyroidism	0.00417	0.211	CbGpPWpGaD
Boceprevir—CTSL—liver—hypothyroidism	0.00413	0.0171	CbGeAlD
Boceprevir—CTSL—cerebellum—hypothyroidism	0.00404	0.0167	CbGeAlD
Boceprevir—CTSS—gonad—hypothyroidism	0.004	0.0165	CbGeAlD
Boceprevir—CTSK—adrenal gland—hypothyroidism	0.00398	0.0164	CbGeAlD
Boceprevir—CTSK—blood—hypothyroidism	0.00398	0.0164	CbGeAlD
Boceprevir—Arrhythmia—Liothyronine—hypothyroidism	0.00394	0.0154	CcSEcCtD
Boceprevir—CTSS—pituitary gland—hypothyroidism	0.00391	0.0161	CbGeAlD
Boceprevir—CTSK—thyroid gland—hypothyroidism	0.00384	0.0159	CbGeAlD
Boceprevir—CTSK—female gonad—hypothyroidism	0.00371	0.0153	CbGeAlD
Boceprevir—CTSS—adrenal gland—hypothyroidism	0.00349	0.0144	CbGeAlD
Boceprevir—CTSS—blood—hypothyroidism	0.00349	0.0144	CbGeAlD
Boceprevir—Cellulitis—Liotrix—hypothyroidism	0.00348	0.0136	CcSEcCtD
Boceprevir—CTSS—thyroid gland—hypothyroidism	0.00337	0.0139	CbGeAlD
Boceprevir—Hypertension—Liothyronine—hypothyroidism	0.00331	0.0129	CcSEcCtD
Boceprevir—CTSK—testis—hypothyroidism	0.00329	0.0136	CbGeAlD
Boceprevir—CTSS—female gonad—hypothyroidism	0.00325	0.0134	CbGeAlD
Boceprevir—CTSK—liver—hypothyroidism	0.00311	0.0128	CbGeAlD
Boceprevir—Affect lability—Dextrothyroxine—hypothyroidism	0.00308	0.012	CcSEcCtD
Boceprevir—Affect lability—Levothyroxine—hypothyroidism	0.00308	0.012	CcSEcCtD
Boceprevir—Wheezing—Liotrix—hypothyroidism	0.00308	0.012	CcSEcCtD
Boceprevir—Tachycardia—Liothyronine—hypothyroidism	0.00305	0.0119	CcSEcCtD
Boceprevir—CTSK—cerebellum—hypothyroidism	0.00304	0.0126	CbGeAlD
Boceprevir—Irritability—Dextrothyroxine—hypothyroidism	0.00298	0.0117	CcSEcCtD
Boceprevir—Irritability—Levothyroxine—hypothyroidism	0.00298	0.0117	CcSEcCtD
Boceprevir—Mood swings—Dextrothyroxine—hypothyroidism	0.00296	0.0116	CcSEcCtD
Boceprevir—Mood swings—Levothyroxine—hypothyroidism	0.00296	0.0116	CcSEcCtD
Boceprevir—Hypotension—Liothyronine—hypothyroidism	0.00292	0.0114	CcSEcCtD
Boceprevir—Dehydration—Dextrothyroxine—hypothyroidism	0.00291	0.0114	CcSEcCtD
Boceprevir—Dehydration—Levothyroxine—hypothyroidism	0.00291	0.0114	CcSEcCtD
Boceprevir—CTSS—testis—hypothyroidism	0.00289	0.0119	CbGeAlD
Boceprevir—Muscular weakness—Levothyroxine—hypothyroidism	0.00276	0.0108	CcSEcCtD
Boceprevir—Muscular weakness—Dextrothyroxine—hypothyroidism	0.00276	0.0108	CcSEcCtD
Boceprevir—Sepsis—Liotrix—hypothyroidism	0.00275	0.0108	CcSEcCtD
Boceprevir—CTSS—liver—hypothyroidism	0.00273	0.0113	CbGeAlD
Boceprevir—Dysphagia—Levothyroxine—hypothyroidism	0.0027	0.0106	CcSEcCtD
Boceprevir—Dysphagia—Dextrothyroxine—hypothyroidism	0.0027	0.0106	CcSEcCtD
Boceprevir—CTSS—cerebellum—hypothyroidism	0.00266	0.011	CbGeAlD
Boceprevir—Body temperature increased—Liothyronine—hypothyroidism	0.00247	0.00968	CcSEcCtD
Boceprevir—Weight decreased—Levothyroxine—hypothyroidism	0.00245	0.00956	CcSEcCtD
Boceprevir—Weight decreased—Dextrothyroxine—hypothyroidism	0.00245	0.00956	CcSEcCtD
Boceprevir—Affect lability—Liotrix—hypothyroidism	0.00226	0.00886	CcSEcCtD
Boceprevir—Irritability—Liotrix—hypothyroidism	0.0022	0.00859	CcSEcCtD
Boceprevir—Mood swings—Liotrix—hypothyroidism	0.00218	0.00852	CcSEcCtD
Boceprevir—Dehydration—Liotrix—hypothyroidism	0.00214	0.00837	CcSEcCtD
Boceprevir—Hypokalaemia—Liotrix—hypothyroidism	0.00209	0.00819	CcSEcCtD
Boceprevir—Muscular weakness—Liotrix—hypothyroidism	0.00203	0.00793	CcSEcCtD
Boceprevir—Flushing—Levothyroxine—hypothyroidism	0.00201	0.00785	CcSEcCtD
Boceprevir—Flushing—Dextrothyroxine—hypothyroidism	0.00201	0.00785	CcSEcCtD
Boceprevir—Abdominal distension—Liotrix—hypothyroidism	0.002	0.00783	CcSEcCtD
Boceprevir—Dysphagia—Liotrix—hypothyroidism	0.00199	0.00778	CcSEcCtD
Boceprevir—Arrhythmia—Dextrothyroxine—hypothyroidism	0.00193	0.00756	CcSEcCtD
Boceprevir—Arrhythmia—Levothyroxine—hypothyroidism	0.00193	0.00756	CcSEcCtD
Boceprevir—Bronchitis—Liotrix—hypothyroidism	0.00191	0.00748	CcSEcCtD
Boceprevir—Alopecia—Dextrothyroxine—hypothyroidism	0.00191	0.00748	CcSEcCtD
Boceprevir—Alopecia—Levothyroxine—hypothyroidism	0.00191	0.00748	CcSEcCtD
Boceprevir—Weight decreased—Liotrix—hypothyroidism	0.0018	0.00703	CcSEcCtD
Boceprevir—Agitation—Levothyroxine—hypothyroidism	0.00173	0.00677	CcSEcCtD
Boceprevir—Agitation—Dextrothyroxine—hypothyroidism	0.00173	0.00677	CcSEcCtD
Boceprevir—Angioedema—Dextrothyroxine—hypothyroidism	0.00172	0.00673	CcSEcCtD
Boceprevir—Angioedema—Levothyroxine—hypothyroidism	0.00172	0.00673	CcSEcCtD
Boceprevir—Palpitations—Dextrothyroxine—hypothyroidism	0.00166	0.00651	CcSEcCtD
Boceprevir—Palpitations—Levothyroxine—hypothyroidism	0.00166	0.00651	CcSEcCtD
Boceprevir—CTSL—MHC class II antigen presentation—CLTC—hypothyroidism	0.00162	0.0821	CbGpPWpGaD
Boceprevir—CTSV—MHC class II antigen presentation—CLTC—hypothyroidism	0.00162	0.0821	CbGpPWpGaD
Boceprevir—Arthralgia—Dextrothyroxine—hypothyroidism	0.0016	0.00627	CcSEcCtD
Boceprevir—Arthralgia—Levothyroxine—hypothyroidism	0.0016	0.00627	CcSEcCtD
Boceprevir—Anxiety—Dextrothyroxine—hypothyroidism	0.0016	0.00625	CcSEcCtD
Boceprevir—Anxiety—Levothyroxine—hypothyroidism	0.0016	0.00625	CcSEcCtD
Boceprevir—Hypoaesthesia—Liotrix—hypothyroidism	0.00158	0.00619	CcSEcCtD
Boceprevir—Confusional state—Levothyroxine—hypothyroidism	0.00155	0.00606	CcSEcCtD
Boceprevir—Confusional state—Dextrothyroxine—hypothyroidism	0.00155	0.00606	CcSEcCtD
Boceprevir—Shock—Dextrothyroxine—hypothyroidism	0.00151	0.00591	CcSEcCtD
Boceprevir—Shock—Levothyroxine—hypothyroidism	0.00151	0.00591	CcSEcCtD
Boceprevir—Tachycardia—Levothyroxine—hypothyroidism	0.0015	0.00587	CcSEcCtD
Boceprevir—Tachycardia—Dextrothyroxine—hypothyroidism	0.0015	0.00587	CcSEcCtD
Boceprevir—Hyperhidrosis—Dextrothyroxine—hypothyroidism	0.00149	0.00581	CcSEcCtD
Boceprevir—Hyperhidrosis—Levothyroxine—hypothyroidism	0.00149	0.00581	CcSEcCtD
Boceprevir—Flushing—Liotrix—hypothyroidism	0.00148	0.00578	CcSEcCtD
Boceprevir—Arrhythmia—Liotrix—hypothyroidism	0.00142	0.00556	CcSEcCtD
Boceprevir—Alopecia—Liotrix—hypothyroidism	0.00141	0.0055	CcSEcCtD
Boceprevir—Musculoskeletal discomfort—Levothyroxine—hypothyroidism	0.0014	0.00548	CcSEcCtD
Boceprevir—Musculoskeletal discomfort—Dextrothyroxine—hypothyroidism	0.0014	0.00548	CcSEcCtD
Boceprevir—Insomnia—Dextrothyroxine—hypothyroidism	0.00139	0.00544	CcSEcCtD
Boceprevir—Insomnia—Levothyroxine—hypothyroidism	0.00139	0.00544	CcSEcCtD
Boceprevir—Dyspnoea—Levothyroxine—hypothyroidism	0.00137	0.00536	CcSEcCtD
Boceprevir—Dyspnoea—Dextrothyroxine—hypothyroidism	0.00137	0.00536	CcSEcCtD
Boceprevir—Flatulence—Liotrix—hypothyroidism	0.00137	0.00534	CcSEcCtD
Boceprevir—Dysgeusia—Liotrix—hypothyroidism	0.00136	0.00531	CcSEcCtD
Boceprevir—CMA1—Peptide hormone metabolism—TSHB—hypothyroidism	0.00135	0.0681	CbGpPWpGaD
Boceprevir—CTSK—MHC class II antigen presentation—CLTC—hypothyroidism	0.00135	0.0681	CbGpPWpGaD
Boceprevir—Fatigue—Dextrothyroxine—hypothyroidism	0.00133	0.00518	CcSEcCtD
Boceprevir—Fatigue—Levothyroxine—hypothyroidism	0.00133	0.00518	CcSEcCtD
Boceprevir—Vision blurred—Liotrix—hypothyroidism	0.00131	0.00511	CcSEcCtD
Boceprevir—Agitation—Liotrix—hypothyroidism	0.00127	0.00498	CcSEcCtD
Boceprevir—Feeling abnormal—Levothyroxine—hypothyroidism	0.00127	0.00495	CcSEcCtD
Boceprevir—Feeling abnormal—Dextrothyroxine—hypothyroidism	0.00127	0.00495	CcSEcCtD
Boceprevir—Angioedema—Liotrix—hypothyroidism	0.00127	0.00495	CcSEcCtD
Boceprevir—Gastrointestinal pain—Dextrothyroxine—hypothyroidism	0.00126	0.00492	CcSEcCtD
Boceprevir—Gastrointestinal pain—Levothyroxine—hypothyroidism	0.00126	0.00492	CcSEcCtD
Boceprevir—Syncope—Liotrix—hypothyroidism	0.00124	0.00486	CcSEcCtD
Boceprevir—Palpitations—Liotrix—hypothyroidism	0.00122	0.00479	CcSEcCtD
Boceprevir—Urticaria—Dextrothyroxine—hypothyroidism	0.00122	0.00478	CcSEcCtD
Boceprevir—Urticaria—Levothyroxine—hypothyroidism	0.00122	0.00478	CcSEcCtD
Boceprevir—Loss of consciousness—Liotrix—hypothyroidism	0.00122	0.00476	CcSEcCtD
Boceprevir—Abdominal pain—Dextrothyroxine—hypothyroidism	0.00122	0.00475	CcSEcCtD
Boceprevir—Body temperature increased—Dextrothyroxine—hypothyroidism	0.00122	0.00475	CcSEcCtD
Boceprevir—Abdominal pain—Levothyroxine—hypothyroidism	0.00122	0.00475	CcSEcCtD
Boceprevir—Body temperature increased—Levothyroxine—hypothyroidism	0.00122	0.00475	CcSEcCtD
Boceprevir—Hypertension—Liotrix—hypothyroidism	0.0012	0.00468	CcSEcCtD
Boceprevir—Arthralgia—Liotrix—hypothyroidism	0.00118	0.00461	CcSEcCtD
Boceprevir—Chest pain—Liotrix—hypothyroidism	0.00118	0.00461	CcSEcCtD
Boceprevir—Anxiety—Liotrix—hypothyroidism	0.00118	0.0046	CcSEcCtD
Boceprevir—CYP3A5—blood—hypothyroidism	0.00116	0.00478	CbGeAlD
Boceprevir—Confusional state—Liotrix—hypothyroidism	0.00114	0.00446	CcSEcCtD
Boceprevir—Infection—Liotrix—hypothyroidism	0.00112	0.00439	CcSEcCtD
Boceprevir—Shock—Liotrix—hypothyroidism	0.00111	0.00435	CcSEcCtD
Boceprevir—CTSS—MHC class II antigen presentation—CLTC—hypothyroidism	0.00111	0.056	CbGpPWpGaD
Boceprevir—Tachycardia—Liotrix—hypothyroidism	0.0011	0.00432	CcSEcCtD
Boceprevir—Asthenia—Dextrothyroxine—hypothyroidism	0.0011	0.00431	CcSEcCtD
Boceprevir—Asthenia—Levothyroxine—hypothyroidism	0.0011	0.00431	CcSEcCtD
Boceprevir—Hyperhidrosis—Liotrix—hypothyroidism	0.00109	0.00427	CcSEcCtD
Boceprevir—Pruritus—Dextrothyroxine—hypothyroidism	0.00109	0.00425	CcSEcCtD
Boceprevir—Pruritus—Levothyroxine—hypothyroidism	0.00109	0.00425	CcSEcCtD
Boceprevir—CYP3A5—female gonad—hypothyroidism	0.00108	0.00446	CbGeAlD
Boceprevir—Hypotension—Liotrix—hypothyroidism	0.00106	0.00413	CcSEcCtD
Boceprevir—Diarrhoea—Levothyroxine—hypothyroidism	0.00105	0.00411	CcSEcCtD
Boceprevir—Diarrhoea—Dextrothyroxine—hypothyroidism	0.00105	0.00411	CcSEcCtD
Boceprevir—Musculoskeletal discomfort—Liotrix—hypothyroidism	0.00103	0.00403	CcSEcCtD
Boceprevir—Insomnia—Liotrix—hypothyroidism	0.00102	0.004	CcSEcCtD
Boceprevir—Paraesthesia—Liotrix—hypothyroidism	0.00102	0.00397	CcSEcCtD
Boceprevir—Dyspnoea—Liotrix—hypothyroidism	0.00101	0.00394	CcSEcCtD
Boceprevir—Decreased appetite—Liotrix—hypothyroidism	0.000983	0.00384	CcSEcCtD
Boceprevir—Vomiting—Dextrothyroxine—hypothyroidism	0.000977	0.00382	CcSEcCtD
Boceprevir—Vomiting—Levothyroxine—hypothyroidism	0.000977	0.00382	CcSEcCtD
Boceprevir—Fatigue—Liotrix—hypothyroidism	0.000975	0.00381	CcSEcCtD
Boceprevir—Rash—Dextrothyroxine—hypothyroidism	0.000969	0.00379	CcSEcCtD
Boceprevir—Rash—Levothyroxine—hypothyroidism	0.000969	0.00379	CcSEcCtD
Boceprevir—Dermatitis—Dextrothyroxine—hypothyroidism	0.000968	0.00379	CcSEcCtD
Boceprevir—Dermatitis—Levothyroxine—hypothyroidism	0.000968	0.00379	CcSEcCtD
Boceprevir—Constipation—Liotrix—hypothyroidism	0.000967	0.00378	CcSEcCtD
Boceprevir—Headache—Levothyroxine—hypothyroidism	0.000963	0.00377	CcSEcCtD
Boceprevir—Headache—Dextrothyroxine—hypothyroidism	0.000963	0.00377	CcSEcCtD
Boceprevir—Feeling abnormal—Liotrix—hypothyroidism	0.000932	0.00364	CcSEcCtD
Boceprevir—Gastrointestinal pain—Liotrix—hypothyroidism	0.000925	0.00362	CcSEcCtD
Boceprevir—Nausea—Levothyroxine—hypothyroidism	0.000913	0.00357	CcSEcCtD
Boceprevir—Nausea—Dextrothyroxine—hypothyroidism	0.000913	0.00357	CcSEcCtD
Boceprevir—CYP3A5—liver—hypothyroidism	0.000906	0.00374	CbGeAlD
Boceprevir—Urticaria—Liotrix—hypothyroidism	0.000898	0.00351	CcSEcCtD
Boceprevir—Abdominal pain—Liotrix—hypothyroidism	0.000894	0.0035	CcSEcCtD
Boceprevir—Body temperature increased—Liotrix—hypothyroidism	0.000894	0.0035	CcSEcCtD
Boceprevir—CYP3A4—blood—hypothyroidism	0.000869	0.00359	CbGeAlD
Boceprevir—ABCB1—adrenal cortex—hypothyroidism	0.000853	0.00352	CbGeAlD
Boceprevir—Hypersensitivity—Liotrix—hypothyroidism	0.000833	0.00326	CcSEcCtD
Boceprevir—ABCB1—heart—hypothyroidism	0.000825	0.0034	CbGeAlD
Boceprevir—Asthenia—Liotrix—hypothyroidism	0.000811	0.00317	CcSEcCtD
Boceprevir—CMA1—Signaling by SCF-KIT—SH2B3—hypothyroidism	0.0008	0.0405	CbGpPWpGaD
Boceprevir—Pruritus—Liotrix—hypothyroidism	0.0008	0.00313	CcSEcCtD
Boceprevir—ABCB1—cardiovascular system—hypothyroidism	0.000778	0.00321	CbGeAlD
Boceprevir—Diarrhoea—Liotrix—hypothyroidism	0.000774	0.00303	CcSEcCtD
Boceprevir—Dizziness—Liotrix—hypothyroidism	0.000748	0.00292	CcSEcCtD
Boceprevir—Vomiting—Liotrix—hypothyroidism	0.000719	0.00281	CcSEcCtD
Boceprevir—Rash—Liotrix—hypothyroidism	0.000713	0.00279	CcSEcCtD
Boceprevir—Dermatitis—Liotrix—hypothyroidism	0.000712	0.00279	CcSEcCtD
Boceprevir—Headache—Liotrix—hypothyroidism	0.000708	0.00277	CcSEcCtD
Boceprevir—ABCB1—gonad—hypothyroidism	0.000706	0.00291	CbGeAlD
Boceprevir—ABCB1—pituitary gland—hypothyroidism	0.000689	0.00284	CbGeAlD
Boceprevir—CTSV—Endochondral Ossification—IGF1—hypothyroidism	0.000684	0.0346	CbGpPWpGaD
Boceprevir—CYP3A4—liver—hypothyroidism	0.00068	0.00281	CbGeAlD
Boceprevir—Nausea—Liotrix—hypothyroidism	0.000672	0.00263	CcSEcCtD
Boceprevir—ABCB1—adrenal gland—hypothyroidism	0.000615	0.00254	CbGeAlD
Boceprevir—ABCB1—blood—hypothyroidism	0.000615	0.00254	CbGeAlD
Boceprevir—ABCB1—thyroid gland—hypothyroidism	0.000594	0.00245	CbGeAlD
Boceprevir—ABCB1—female gonad—hypothyroidism	0.000574	0.00237	CbGeAlD
Boceprevir—CMA1—Peptide hormone metabolism—POMC—hypothyroidism	0.000527	0.0267	CbGpPWpGaD
Boceprevir—ABCB1—testis—hypothyroidism	0.000509	0.0021	CbGeAlD
Boceprevir—CMA1—Peptide hormone metabolism—IGF1—hypothyroidism	0.000507	0.0256	CbGpPWpGaD
Boceprevir—ABCB1—liver—hypothyroidism	0.000481	0.00199	CbGeAlD
Boceprevir—ABCB1—cerebellum—hypothyroidism	0.00047	0.00194	CbGeAlD
Boceprevir—CTSL—Adaptive Immune System—CLTC—hypothyroidism	0.00039	0.0197	CbGpPWpGaD
Boceprevir—CTSV—Adaptive Immune System—CLTC—hypothyroidism	0.00039	0.0197	CbGpPWpGaD
Boceprevir—CTSK—Adaptive Immune System—CLTC—hypothyroidism	0.000323	0.0163	CbGpPWpGaD
Boceprevir—CTSS—Adaptive Immune System—CLTC—hypothyroidism	0.000266	0.0135	CbGpPWpGaD
Boceprevir—CMA1—Metabolism of proteins—TSHB—hypothyroidism	0.000254	0.0128	CbGpPWpGaD
Boceprevir—CTSL—Immune System—CLTC—hypothyroidism	0.000237	0.012	CbGpPWpGaD
Boceprevir—CTSV—Immune System—CLTC—hypothyroidism	0.000237	0.012	CbGpPWpGaD
Boceprevir—CTSK—Immune System—CLTC—hypothyroidism	0.000196	0.00991	CbGpPWpGaD
Boceprevir—CTSV—Innate Immune System—VAV3—hypothyroidism	0.000191	0.00968	CbGpPWpGaD
Boceprevir—CTSL—Innate Immune System—VAV3—hypothyroidism	0.000191	0.00968	CbGpPWpGaD
Boceprevir—CTSS—Immune System—CLTC—hypothyroidism	0.000161	0.00816	CbGpPWpGaD
Boceprevir—CTSK—Innate Immune System—VAV3—hypothyroidism	0.000159	0.00802	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—CLTC—hypothyroidism	0.000142	0.00719	CbGpPWpGaD
Boceprevir—CTSS—Innate Immune System—VAV3—hypothyroidism	0.000131	0.0066	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—TRH—hypothyroidism	0.000123	0.00621	CbGpPWpGaD
Boceprevir—CTSL—Immune System—PRL—hypothyroidism	0.00012	0.00609	CbGpPWpGaD
Boceprevir—CTSV—Immune System—PRL—hypothyroidism	0.00012	0.00609	CbGpPWpGaD
Boceprevir—CYP3A5—Cytochrome P450 - arranged by substrate type—POMC—hypothyroidism	0.000112	0.00565	CbGpPWpGaD
Boceprevir—CTSL—Immune System—VAV3—hypothyroidism	0.000111	0.00564	CbGpPWpGaD
Boceprevir—CTSV—Immune System—VAV3—hypothyroidism	0.000111	0.00564	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—TSHB—hypothyroidism	0.00011	0.00554	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—TSHR—hypothyroidism	0.00011	0.00554	CbGpPWpGaD
Boceprevir—CTSK—Immune System—PRL—hypothyroidism	9.98e-05	0.00505	CbGpPWpGaD
Boceprevir—CMA1—Metabolism of proteins—POMC—hypothyroidism	9.95e-05	0.00503	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—SH2B3—hypothyroidism	9.76e-05	0.00494	CbGpPWpGaD
Boceprevir—CMA1—Metabolism of proteins—IGF1—hypothyroidism	9.57e-05	0.00484	CbGpPWpGaD
Boceprevir—CTSK—Immune System—VAV3—hypothyroidism	9.24e-05	0.00467	CbGpPWpGaD
Boceprevir—CYP3A5—Phase 1 - Functionalization of compounds—POMC—hypothyroidism	9.05e-05	0.00458	CbGpPWpGaD
Boceprevir—CTSS—Immune System—PRL—hypothyroidism	8.22e-05	0.00416	CbGpPWpGaD
Boceprevir—CTSS—Immune System—VAV3—hypothyroidism	7.61e-05	0.00385	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—PRL—hypothyroidism	7.24e-05	0.00366	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—VAV3—hypothyroidism	6.7e-05	0.00339	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—AVP—hypothyroidism	6.45e-05	0.00326	CbGpPWpGaD
Boceprevir—ABCB1—Transmembrane transport of small molecules—SLC5A7—hypothyroidism	6.34e-05	0.0032	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—IYD—hypothyroidism	5.67e-05	0.00287	CbGpPWpGaD
Boceprevir—ABCB1—Transmembrane transport of small molecules—SLC26A4—hypothyroidism	5.25e-05	0.00265	CbGpPWpGaD
Boceprevir—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—hypothyroidism	5.19e-05	0.00262	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—ATP5O—hypothyroidism	4.82e-05	0.00244	CbGpPWpGaD
Boceprevir—CYP3A5—Biological oxidations—POMC—hypothyroidism	4.81e-05	0.00243	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—TPO—hypothyroidism	4.54e-05	0.00229	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—POMC—hypothyroidism	4.29e-05	0.00217	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—IYD—hypothyroidism	4.28e-05	0.00216	CbGpPWpGaD
Boceprevir—CYP3A4—Phase 1 - Functionalization of compounds—POMC—hypothyroidism	4.21e-05	0.00213	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—IGF1—hypothyroidism	4.13e-05	0.00209	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—ATP5O—hypothyroidism	3.64e-05	0.00184	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—TPO—hypothyroidism	3.42e-05	0.00173	CbGpPWpGaD
Boceprevir—ABCB1—Integrated Pancreatic Cancer Pathway—IGF1—hypothyroidism	3.21e-05	0.00162	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—IYD—hypothyroidism	2.64e-05	0.00133	CbGpPWpGaD
Boceprevir—ABCB1—Transmembrane transport of small molecules—SLC5A5—hypothyroidism	2.53e-05	0.00128	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—ATP5O—hypothyroidism	2.24e-05	0.00113	CbGpPWpGaD
Boceprevir—CYP3A4—Biological oxidations—POMC—hypothyroidism	2.24e-05	0.00113	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—TPO—hypothyroidism	2.11e-05	0.00107	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—TSHB—hypothyroidism	2.1e-05	0.00106	CbGpPWpGaD
Boceprevir—ABCB1—Transmembrane transport of small molecules—AVP—hypothyroidism	1.99e-05	0.00101	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—PIK3C2A—hypothyroidism	1.87e-05	0.000946	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—TSHB—hypothyroidism	1.58e-05	0.000801	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—SLC5A5—hypothyroidism	1.57e-05	0.000795	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—PIK3C2A—hypothyroidism	1.41e-05	0.000714	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—SLC5A5—hypothyroidism	1.19e-05	0.0006	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—TSHB—hypothyroidism	9.76e-06	0.000494	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—PIK3C2A—hypothyroidism	8.7e-06	0.00044	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—POMC—hypothyroidism	8.22e-06	0.000416	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—SLC5A5—hypothyroidism	7.31e-06	0.000369	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—POMC—hypothyroidism	6.21e-06	0.000314	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—POMC—hypothyroidism	3.82e-06	0.000193	CbGpPWpGaD
